An NIR-Fluorophore-Based Therapeutic Endoplasmic Reticulum Stress Inducer.
Yang WangShenglin LuoChi ZhangXingyun LiaoTao LiuZhongyong JiangDengqun LiuXu TanLei LongYu WangZelin ChenYunsheng LiuFan YangYibo GanChunmeng ShiPublished in: Advanced materials (Deerfield Beach, Fla.) (2018)
The endoplasmic reticulum (ER) stress signaling or unfolded protein response (UPR) is a common feature of many human diseases, including cancer. Excessive activation of ER stress directly induces cell death, holding a new promising strategy for the therapeutic intervention of cancer. Current ER-stress-inducing agents mainly target UPR components or proteasomes, which exert limited treatment efficacy and undesired side effects due to unselective ER stress and poor tumor-specific distribution. In this study, a unique near-infrared (NIR) fluorophore, IR-34, is synthesized and identified to selectively and efficiently trigger tumoricidal ER stress by targeting the mitochondrial protein NDUFS1. IR-34 is demonstrated to specifically accumulate in living cancer cells for tumor NIR imaging and drastically inhibit tumor growth and recurrence without causing apparent toxicity. Thus, this multifunctional NIR fluorophore may represent a novel theranostic agent for tumor imaging-guided treatment and also strengthens the idea that mitochondria could be a useful target for therapeutic ER stress in cancer cells.
Keyphrases
- fluorescent probe
- endoplasmic reticulum stress
- endoplasmic reticulum
- photodynamic therapy
- fluorescence imaging
- cell death
- papillary thyroid
- drug release
- high resolution
- induced apoptosis
- oxidative stress
- randomized controlled trial
- endothelial cells
- squamous cell
- drug delivery
- machine learning
- protein protein
- cell proliferation
- physical activity
- squamous cell carcinoma
- combination therapy
- childhood cancer
- computed tomography
- reactive oxygen species
- replacement therapy
- metal organic framework
- diffusion weighted imaging